Immunotherapy successful against deadly breast cancer
 

A new trial confirms that a combination of immunotherapy and chemotherapy boosts survival rates for people with triple-negative breast cancer.

More...

Re: Immunotherapy successful against deadly breast cancer
 

The new imunotherapy drug isnt really new. it is another PD1 inhibitor with a brand name of Tecentriq. My computer was down and I was a bit frustrated because I was curious about Tecentriq thinking it was something new. I printed out the package insert and will read it today but my educated guess is Opdivo or Keytruda added to the chemo would give the same results as Tecentriq. I hope Im wrong

Paul